Suppr超能文献

采用容积调强弧形治疗技术进行全骨髓淋巴照射的可行性研究:在三级护理中心的临床实施。

Feasibility study of total marrow lymphoid irradiation with volumetric modulated arc therapy: clinical implementation in a tertiary care center.

机构信息

Department of Radiation Oncology, Christian Medical College, 632 004, Vellore, Tamil Nadu, India.

Department of Radiation Oncology, Amala Institute of Medical Sciences, Trissur, Kerala, India.

出版信息

Strahlenther Onkol. 2023 Oct;199(10):922-935. doi: 10.1007/s00066-023-02100-x. Epub 2023 Jun 6.

Abstract

PURPOSE

Total marrow lymphoid irradiation (TMLI) with volumetric modulated arc therapy (VMAT) is challenging due to large treatment fields with multiple isocenters, field matching at junctions, and targets being surrounded by many organs at risk. This study aimed to describe our methodology for safe dose escalation and accurate dose delivery of TMLI treatment with the VMAT technique based on early experience at our center.

MATERIALS AND METHODS

Computed tomography (CT) scans were acquired in head-first supine and feet-first supine orientations for each patient with an overlap at mid-thigh. VMAT plans were generated for 20 patients on the head-first CT images with either three or four isocenters in the Eclipse treatment planning system (Varian Medical Systems Inc., Palo Alto, CA) and the treatment was delivered in a Clinac 2100 C/D linear accelerator (Varian Medical Systems Inc., Palo Alto, CA).

RESULTS

Five patients were treated with a prescription dose of 13.5 Gy in 9 fractions and 15 patients were treated with an escalated dose of 15 Gy in 10 fractions. The mean doses to 95% of the clinical target volume (CTV) and planning target volume (PTV) were 14.3 ± 0.3 Gy and 13.6 ± 0.7 Gy for the prescription doses of 15 Gy, and 13 ± 0.2 Gy and 12.3 ± 0.3 Gy for the prescription doses of 13.5 Gy, respectively. Mean dose to the lung in both schedules was 8.7 ± 0.6 Gy. The overall time taken to execute the treatment plans was approximately 2 h for the first fraction and 1.5 h for subsequent fractions. The average in-room time of 15.5 h per patient over 5 days leads to potential changes in the regular treatment schedules for other patients.

CONCLUSION

This feasibility study highlights the methodology adopted for safe implementation of TMLI with the VMAT technique at our institution. Escalation of dose to the target with adequate coverage and sparing of critical structures was achieved with the adopted treatment technique. Clinical implementation of this methodology at our center could serve as a practical guide to start the VMAT-based TMLI program safely by others who are keen to start this service.

摘要

目的

由于治疗野较大且有多个等中心点、野衔接处的匹配以及靶区周围有许多危及器官,因此使用容积调强弧形治疗(VMAT)进行全骨髓淋巴照射(TMLI)具有挑战性。本研究旨在描述我们基于中心早期经验,采用 VMAT 技术对 TMLI 治疗进行安全剂量递增和准确剂量传递的方法。

材料和方法

对每位患者在头部首先仰卧位和脚部首先仰卧位采集 CT 扫描,在大腿中部重叠。在 Eclipse 治疗计划系统(Varian Medical Systems Inc.,Palo Alto,CA)上对头部 CT 图像生成 20 例患者的 VMAT 计划,每个计划有三个或四个等中心点,在 Clinac 2100 C/D 直线加速器(Varian Medical Systems Inc.,Palo Alto,CA)上进行治疗。

结果

5 例患者采用 13.5Gy/9 次的处方剂量进行治疗,15 例患者采用 15Gy/10 次的递增剂量进行治疗。95%的临床靶体积(CTV)和计划靶体积(PTV)的平均剂量分别为处方剂量为 15Gy 时的 14.3±0.3Gy 和 13.6±0.7Gy,处方剂量为 13.5Gy 时的 13±0.2Gy 和 12.3±0.3Gy。两种方案中肺的平均剂量均为 8.7±0.6Gy。完成治疗计划的总时间大约为第一部分的 2 小时和随后部分的 1.5 小时。每位患者在 5 天内的平均在室时间为 15.5 小时,这可能会改变其他患者的常规治疗计划。

结论

本可行性研究强调了我们机构采用 VMAT 技术安全实施 TMLI 的方法。采用所采用的治疗技术,实现了目标剂量的递增,同时充分覆盖并保护了关键结构。本中心采用这种方法进行临床实施,可以为其他热衷于开展这项服务的人提供安全开展基于 VMAT 的 TMLI 项目的实用指南。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验